Tweets by FSCDR's 17th Annual SCD Research and Educational Symposium & 46th Nat'l SCD Scientific Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Stream

NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.

Investigational New Drug, Device and Therapeutics Symposium

Novo Nordisk in Sickle Cell Disease

Friday, June 16, 2023

4:15 PM – 4:25 PM East Coast USA Time

Location: Grand Salons A-E

Speaker(s)

Adam Wufsus, PhD (he/him/his)

Medical Director, Rare Blood Disorders
Novo Nordisk, Inc.
Plainsboro, New Jersey, United States

Slides

Disclosure(s):

Adam Wufsus, PhD: No relevant disclosure to display

Learning Objectives:

Upon completion, participant will be able to describe Novo Nordisk's approach to Rare Disease, including Sickle Cell Disease
Upon completion, participant will be able to describe the Etavopivat development program.
Upon completion, participant will be able to describe the NDec development program.